Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study was planned before the COVID-19 pandemic and will not be pursued due to a change in research focus post-pandemic.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Dr. Peter C. Fritz, Periodontal Wellness & Implant Surgery | OTHER |
Not provided
Not provided
Not provided
Not provided
The aim of this study is to investigate the effectiveness of daily supplementation with inulin before, during and after sanative therapy (ST), on clinical outcomes of periodontal disease. The study design will allow the investigators to conclude if supplementation with inulin can favourably modulate oral microbiota prior to ST and can result in better periodontal health after ST.
Periodontal disease is a chronic state of inflammation that can destroy the supporting tissues around the teeth, leading to a loss of connective tissue and the periodontal ligament, the resorption of alveolar bone and eventual tooth loss. Periodontal disease can also induce dysbiosis in the gut microbiome and contribute to low grade systemic inflammation. Prebiotic fibres such as inulin can selectively alter the intestinal microbiota to bring back a state of homeostasis by improving gut barrier functions and preventing inflammation. Through this mechanism, supplementation with inulin may be able to indirectly benefit periodontal health. The primary objective of this trial to determine if inulin supplementation, provided pre-sanative therapy (ST) through the healing phase (post-ST) is more effective than the placebo at improving clinical outcomes of periodontal health: decreasing both the number of sites with probing depths greater than or equal to 4 mm and increasing the absence of bleeding on probing (BOP). Secondary objectives include determining the effects of inulin supplementation pre- and post-ST on salivary markers of inflammation and periodontal-associated pathogens.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Inulin | Experimental | Supplementation with inulin for 4 weeks prior to and 10 weeks after sanative therapy. 10 g daily, divided into two equal doses. |
|
| Placebo | Placebo Comparator | Supplementation with maltodextrin (as placebo) for 4 weeks prior to and 10 weeks after sanative therapy. 10 g daily, divided into two equal doses. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Inulin | Dietary Supplement | Supplementation with a prebiotic, specifically inulin. |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Probing depth | This is a routine clinical measure of periodontal health (measured in mm) | At pre-sanative therapy |
| Probing depth | This is a routine clinical measure of periodontal health (measured in mm) | At post-sanative therapy (10 weeks after sanative therapy is completed) |
| Bleeding on probing (BOP) | This is a clinical measure of inflammation and represented as the percentage to bleeding sites that are measured at 6 sites per tooth | At pre-sanative therapy |
| Bleeding on probing (BOP) | This is a clinical measure of inflammation and represented as the percentage to bleeding sites that are measured at 6 sites per tooth | At post-sanative therapy (10 weeks after sanative therapy is completed) |
| Measure | Description | Time Frame |
|---|---|---|
| Salivary markers of inflammation | Levels of interleukin (IL)-1beta, IL-6, C-reactive protein (CRP), Matrix metalloproteinase-8 will be measured. | At pre-sanative therapy |
| Salivary markers of inflammation |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Wendy E Ward, PhD | Brock University | Principal Investigator |
Not provided
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 34376241 | Derived | Zanatta CAR, Fritz PC, Comelli EM, Ward WE. Intervention with inulin prior to and during sanative therapy to further support periodontal health: study protocol for a randomized controlled trial. Trials. 2021 Aug 10;22(1):527. doi: 10.1186/s13063-021-05504-1. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D010518 | Periodontitis |
| D010510 | Periodontal Diseases |
| D010514 | Periodontal Pocket |
| ID | Term |
|---|---|
| D009059 | Mouth Diseases |
| D009057 | Stomatognathic Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D007444 | Inulin |
| C008315 | maltodextrin |
| ID | Term |
|---|---|
| D013213 | Starch |
| D005936 | Glucans |
| D001704 | Biopolymers |
| D011108 | Polymers |
| D046911 |
Not provided
Not provided
Subjects will be randomized to receive one of the two treatments. They will be required to take one sachet per day (half in the morning; half in the evening) of the assigned intervention beginning 4 weeks before their scheduled sanative therapy appointment and remain on the intervention until 10 weeks after their sanative therapy appointment.
Not provided
Not provided
The intervention packages will be labelled with a unique code and there will be enough packages to account for the required number of participants. A member of the research team, not involved in providing the treatment, will be responsible for the randomization and labeling of the intervention packages, as well as creating a master list by matching the unique code to the treatment arm. The patient and care provider will be masked to the treatment arm.
| Maltodextrin |
| Dietary Supplement |
Supplementation with maltodextrin (placebo) |
|
Levels of interleukin (IL)-1beta, IL-6, C-reactive protein (CRP), Matrix metalloproteinase-8 will be measured.
| At sanative therapy (6 weeks after pre-sanative appointment) |
| Salivary markers of inflammation | Levels of interleukin (IL)-1beta, IL-6, C-reactive protein (CRP), Matrix metalloproteinase-8 will be measured. | At post-sanative therapy (10 weeks after sanative therapy is completed) |
| Periodontal-Associated Pathogens | Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, Tannerella forsythia, Treponema denticola will be measured by quantitative polymerase chain reaction (PCR). | At pre-sanative therapy |
| Periodontal-Associated Pathogens | Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, Tannerella forsythia, Treponema denticola will be measured by quantitative PCR. | At sanative therapy (6 weeks after pre-sanative appointment) |
| Periodontal-Associated Pathogens | Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, Tannerella forsythia, Treponema denticola will be measured by quantitative PCR. | At post-sanative therapy (10 weeks after sanative therapy is completed) |
| Dietary assessment | Intake of energy, carbohydrate, fat and protein will be measured with the automated self-administered dietary intake (ASA-24) questionnaire. This is an online food recall that patients will complete three times for each visit, reporting on their dietary intake from the last 24 hours. | At pre-sanative therapy |
| Dietary assessment | Intake of energy, carbohydrate, fat and protein will be measured with the automated self-administered dietary intake (ASA-24) questionnaire. This is an online food recall that patients will complete three times for each visit, reporting on their dietary intake from the last 24 hours. | At sanative therapy (6 weeks after pre-sanative appointment) |
| Dietary assessment | Intake of energy, carbohydrate, fat and protein will be measured with the automated self-administered dietary intake (ASA-24) questionnaire. This is an online food recall that patients will complete three times for each visit, reporting on their dietary intake from the last 24 hours. | At post-sanative therapy (10 weeks after sanative therapy is completed) |
| Body Mass Index | Body weight and height will be measured to calculate BMI | At pre-sanative therapy |
| Body Mass Index | Body weight and height will be measured to calculate BMI | At sanative therapy (6 weeks after pre-sanative appointment) |
| Body Mass Index | Body weight and height will be measured to calculate BMI | At post-sanative therapy (10 weeks after sanative therapy is completed) |
| Macromolecular Substances |
| D004040 | Dietary Carbohydrates |
| D002241 | Carbohydrates |
| D005630 | Fructans |
| D011134 | Polysaccharides |